Wolfgang F Richter (Wolfgang Richter)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

International journal of toxicology

Journal of cancer research and clinical oncology

Nature communications

Roche Innovation Center Basel

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Roche Innovation Center Basel

Switzerland

DMPK Project Leader / Expert Scientist :: Pharmaceutical Sciences

Publications

Neelakshi Mungra, Fleury Augustin Nsole Biteghe, Zaria Malindi, Allan M Huysamen, Maryam Karaan, Natasha S Hardcastle, Rubina Bunjun, Shivan Chetty, Krupa Naran, Dirk Lang, Wolfgang F Richter, Roger Hunter, Stefan Barth
CSPG4 as a target for the specific killing of triple-negative breast cancer cells by a recombinant SNAP-tag-based antibody-auristatin F drug conjugate. Journal of cancer research and clinical oncology (2023)
Adam Hey, Andreas Baumann, Sven Kronenberg, Guenter Blaich, Silke Mohl, Rajni Fagg, Peter Ulrich, Benno Rattel, Wolfgang F Richter, Andrea Kiessling, Lucinda Weir
Nonclinical Development of Biologics: Integrating Safety, Pharmacokinetics, and Pharmacodynamics to Create Smarter and More Flexible Nonclinical Safety Programs Optimizing Animal Use. International journal of toxicology 40 (3) (2021)
Simone Schadt, Simon Hauri, Filipe Lopes, Martin R Edelmann, Roland F Staack, Roberto Villaseñor, Hubert Kettenberger, Adrian B Roth, Franz Schuler, Wolfgang F Richter, Christoph Funk
Are Biotransformation Studies of Therapeutic Proteins Needed? Scientific Considerations and Technical Challenges. Drug metabolism and disposition: the biological fate of chemicals 47 (12) (2020)
Martina Geiger, Kay-Gunnar Stubenrauch, Johannes Sam, Wolfgang F Richter, Gregor Jordan, Jan Eckmann, Carina Hage, Valeria Nicolini, Anne Freimoser-Grundschober, Mirko Ritter, Matthias E Lauer, Henning Stahlberg, Philippe Ringler, Jigar Patel, Eric Sullivan, Sandra Grau-Richards, Stefan Endres, Sebastian Kobold, Pablo Umaña, Peter Brünker, Christiane Neumann
Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody. Nature communications 11 (1) (2020)

Wolfgang F Richter.css-eqlu8i{font-size:small;padding-left:4px;} (Wolfgang Richter)

Publication Activity (10 Years)

Top Topics

Top Venues

Wolfgang F Richter (Wolfgang Richter)